IBDEI1NQ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28153,1,2,0)
 ;;=2^90715
 ;;^UTILITY(U,$J,358.3,28153,1,3,0)
 ;;=3^TDAP VACCINE
 ;;^UTILITY(U,$J,358.3,28154,0)
 ;;=90716^^111^1408^34^^^^1
 ;;^UTILITY(U,$J,358.3,28154,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28154,1,2,0)
 ;;=2^90716
 ;;^UTILITY(U,$J,358.3,28154,1,3,0)
 ;;=3^VARIVAX (CHICKEN POX) VACCINE
 ;;^UTILITY(U,$J,358.3,28155,0)
 ;;=90664^^111^1408^8^^^^1
 ;;^UTILITY(U,$J,358.3,28155,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28155,1,2,0)
 ;;=2^90664
 ;;^UTILITY(U,$J,358.3,28155,1,3,0)
 ;;=3^FLU VACCINE INTRANASAL
 ;;^UTILITY(U,$J,358.3,28156,0)
 ;;=90749^^111^1408^6^^^^1
 ;;^UTILITY(U,$J,358.3,28156,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28156,1,2,0)
 ;;=2^90749
 ;;^UTILITY(U,$J,358.3,28156,1,3,0)
 ;;=3^DTP VACCINE, IM
 ;;^UTILITY(U,$J,358.3,28157,0)
 ;;=90656^^111^1408^11^^^^1
 ;;^UTILITY(U,$J,358.3,28157,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28157,1,2,0)
 ;;=2^90656
 ;;^UTILITY(U,$J,358.3,28157,1,3,0)
 ;;=3^FLU VACCINE SINGLE DOSE SYRINGE (AFLURIA)
 ;;^UTILITY(U,$J,358.3,28158,0)
 ;;=90691^^111^1408^33^^^^1
 ;;^UTILITY(U,$J,358.3,28158,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28158,1,2,0)
 ;;=2^90691
 ;;^UTILITY(U,$J,358.3,28158,1,3,0)
 ;;=3^TYPHOID VACCINE IM
 ;;^UTILITY(U,$J,358.3,28159,0)
 ;;=90670^^111^1408^27^^^^1
 ;;^UTILITY(U,$J,358.3,28159,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28159,1,2,0)
 ;;=2^90670
 ;;^UTILITY(U,$J,358.3,28159,1,3,0)
 ;;=3^PREVNAR VACCINE
 ;;^UTILITY(U,$J,358.3,28160,0)
 ;;=90661^^111^1408^9^^^^1
 ;;^UTILITY(U,$J,358.3,28160,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28160,1,2,0)
 ;;=2^90661
 ;;^UTILITY(U,$J,358.3,28160,1,3,0)
 ;;=3^FLU VACCINE LOW DOSE SYRINGE (FLUCELVAX)
 ;;^UTILITY(U,$J,358.3,28161,0)
 ;;=90662^^111^1408^7^^^^1
 ;;^UTILITY(U,$J,358.3,28161,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28161,1,2,0)
 ;;=2^90662
 ;;^UTILITY(U,$J,358.3,28161,1,3,0)
 ;;=3^FLU VACCINE HIGH DOSE SYRINGE (FLUZONE)
 ;;^UTILITY(U,$J,358.3,28162,0)
 ;;=90697^^111^1408^5^^^^1
 ;;^UTILITY(U,$J,358.3,28162,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28162,1,2,0)
 ;;=2^90697
 ;;^UTILITY(U,$J,358.3,28162,1,3,0)
 ;;=3^DTAP-IPV-HIB-HEPB VACCINE IM
 ;;^UTILITY(U,$J,358.3,28163,0)
 ;;=90625^^111^1408^2^^^^1
 ;;^UTILITY(U,$J,358.3,28163,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28163,1,2,0)
 ;;=2^90625
 ;;^UTILITY(U,$J,358.3,28163,1,3,0)
 ;;=3^CHOLERA VACCINE,ORAL
 ;;^UTILITY(U,$J,358.3,28164,0)
 ;;=90620^^111^1408^22^^^^1
 ;;^UTILITY(U,$J,358.3,28164,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28164,1,2,0)
 ;;=2^90620
 ;;^UTILITY(U,$J,358.3,28164,1,3,0)
 ;;=3^MENINGOCOCCAL VACCINE,PROTEIN/OUT MEM IM
 ;;^UTILITY(U,$J,358.3,28165,0)
 ;;=90621^^111^1408^21^^^^1
 ;;^UTILITY(U,$J,358.3,28165,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28165,1,2,0)
 ;;=2^90621
 ;;^UTILITY(U,$J,358.3,28165,1,3,0)
 ;;=3^MENINGOCOCCAL VACCINE,LIPOPROTEIN IM
 ;;^UTILITY(U,$J,358.3,28166,0)
 ;;=96365^^111^1409^9^^^^1
 ;;^UTILITY(U,$J,358.3,28166,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28166,1,2,0)
 ;;=2^96365
 ;;^UTILITY(U,$J,358.3,28166,1,3,0)
 ;;=3^THER/PROPH/DIAG IV INF INIT HR
 ;;^UTILITY(U,$J,358.3,28167,0)
 ;;=96366^^111^1409^10^^^^1
 ;;^UTILITY(U,$J,358.3,28167,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28167,1,2,0)
 ;;=2^96366
 ;;^UTILITY(U,$J,358.3,28167,1,3,0)
 ;;=3^THER/PROPH/DIAG IV INF EA ADD HR
 ;;^UTILITY(U,$J,358.3,28168,0)
 ;;=96367^^111^1409^11^^^^1
 ;;^UTILITY(U,$J,358.3,28168,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28168,1,2,0)
 ;;=2^96367
 ;;^UTILITY(U,$J,358.3,28168,1,3,0)
 ;;=3^TX/PROPH/DX IV INF,ADDL SEQ
